Clinical Trial

A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study mainly evaluated the efficacy and safety of Cadonilimab combined with chemotherapy followed by concurrent chemoradiotherapy versus standard concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-06
Trial Details
NCT Number NCT07400536
Lead Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators: Akesobio
Conditions Locally Advanced Cervical Carcinoma
Enrollment 378 participants
Start Date 2026-04-24
Primary Completion 2028-07-18 (estimated)
Study Completion 2032-07-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-13